Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Investigational New Drugs|May 17, 2013
A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancerK H Park, J H Sohn, S Lee, et al.
Bone Marrow Transplantation|March 26, 2014
PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALLS-H Shin, J-H Yoon, S-A Yahng, et al.
Bone Marrow Transplantation|August 12, 2014
Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantationJ-H Yoon, H-J Kim, J-W Kim, et al.
Bone Marrow Transplantation|June 28, 2016
Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioningS H Shin, Y W Jeon, J H Yoon, et al.
Bone Marrow Transplantation|November 7, 2012
Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failureS-H Shin, S-A Yahng, J-H Yoon, et al.
Leukemia|June 19, 2012
Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemiaS Lee, D-W Kim, B-S Cho, et al.
Bone Marrow Transplantation|July 30, 2013
Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?J-H Yoon, W-S Min, H-Je Kim, et al.
Bone Marrow Transplantation|September 25, 2012
Risk and prognostic factors for acute GVHD based on NIH consensus criteriaS-E Lee, B-S Cho, J-H Kim, et al.
Bone Marrow Transplantation|November 29, 2016
Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndromeS-A Yahng, Y-W Jeon, J-H Yoon, et al.
Bone Marrow Transplantation|December 16, 2014
Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALLM Kim, J Park, D-W Kim, et al.
Pageof 18